163 related articles for article (PubMed ID: 29216279)
1. Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study.
Hwang IC; Chang J; Park SM
PLoS One; 2017; 12(12):e0189114. PubMed ID: 29216279
[TBL] [Abstract][Full Text] [Related]
2. Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study.
Hwang IC; Chang J; Park SM
PLoS One; 2018; 13(9):e0203918. PubMed ID: 30208110
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors use and the risk of fatty liver disease: A nationwide cohort study.
Pyo JH; Kim TJ; Lee H; Choi SC; Cho SJ; Choi YH; Min YW; Min BH; Lee JH; Kang M; Lee YC; Kim JJ
J Gastroenterol Hepatol; 2021 May; 36(5):1235-1243. PubMed ID: 32886822
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
[TBL] [Abstract][Full Text] [Related]
5. A Nationwide Population-Based Cohort Study of Dementia Risk Among Acid Suppressant Users.
Hwang IC; Chang J; Park SM
Am J Geriatr Psychiatry; 2018 Nov; 26(11):1175-1183. PubMed ID: 30072307
[TBL] [Abstract][Full Text] [Related]
6. Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies.
Babic A; Zhang X; Morales-Oyarvide V; Yuan C; Khalaf N; Khalili H; Lochhead P; Chan AT; Ogino S; Wolpin BM; Wu K; Fuchs CS; Giovannucci EL; Stampfer MJ; Ng K
Br J Cancer; 2020 Sep; 123(5):844-851. PubMed ID: 32541871
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors and the risk of colorectal cancer: a systematic review and meta-analysis of observational studies.
Ma T; Wu M; Jia S; Yang L
Int J Colorectal Dis; 2020 Dec; 35(12):2157-2169. PubMed ID: 32808072
[TBL] [Abstract][Full Text] [Related]
8. The association between proton pump inhibitor use and the risk of tuberculosis: A case-control study.
Song HJ; Park H; Park S; Kwon JW
Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):830-839. PubMed ID: 30920070
[TBL] [Abstract][Full Text] [Related]
9. Association between use of proton pump inhibitors and colorectal cancer: A nationwide population-based study.
Lei WY; Wang JH; Yi CH; Liu TT; Hung JS; Wong MW; Bair MJ; Vaezi MF; Orr WC; Chen CL
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101397. PubMed ID: 32224118
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant drugs with or without proton pump inhibitor and colorectal cancer risk: a population-based, case-control study.
Ho PH; Hsiao HC; Chen CW; Chen HM; Lim SN; Yeh CT; Kuo CJ; Lin WR
BMC Gastroenterol; 2022 May; 22(1):225. PubMed ID: 35534834
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study.
Robertson DJ; Larsson H; Friis S; Pedersen L; Baron JA; Sørensen HT
Gastroenterology; 2007 Sep; 133(3):755-60. PubMed ID: 17678921
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor-related headaches: a nationwide population-based case-crossover study in Taiwan.
Liang JF; Chen YT; Fuh JL; Li SY; Chen TJ; Tang CH; Wang SJ
Cephalalgia; 2015 Mar; 35(3):203-10. PubMed ID: 24853165
[TBL] [Abstract][Full Text] [Related]
13. Association between proton pump inhibitors use and risk of asthma in Korea: A prevalent new-user cohort study.
Lim HJ; Oh IS; Noh Y; Yon DK; Shin JY
Medicine (Baltimore); 2024 Jan; 103(1):e36772. PubMed ID: 38181266
[TBL] [Abstract][Full Text] [Related]
14. The relationship between proton pump inhibitor adherence and fracture risk in the elderly.
Ding J; Heller DA; Ahern FM; Brown TV
Calcif Tissue Int; 2014 Jun; 94(6):597-607. PubMed ID: 24706060
[TBL] [Abstract][Full Text] [Related]
15. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.
Lewis JR; Barre D; Zhu K; Ivey KL; Lim EM; Hughes J; Prince RL
J Bone Miner Res; 2014 Nov; 29(11):2489-97. PubMed ID: 24825180
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors and colorectal cancer: A systematic review.
Patel A; Spychalski P; Antoszewska M; Regula J; Kobiela J
World J Gastroenterol; 2021 Nov; 27(44):7716-7733. PubMed ID: 34908809
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors and survival in patients with colorectal cancer: a Swedish population-based cohort study.
Wang X; Liu Q; Halfdanarson ÓÖ; Zoega H; Sadr-Azodi O; Engstrand L; Fall K; Brusselaers N
Br J Cancer; 2021 Sep; 125(6):893-900. PubMed ID: 34253872
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer risk in relation to use of acid suppressive medications.
Chubak J; Boudreau DM; Rulyak SJ; Mandelson MT
Pharmacoepidemiol Drug Saf; 2009 Jul; 18(7):540-4. PubMed ID: 19367565
[TBL] [Abstract][Full Text] [Related]
19. Use of proton pump inhibitors and the risk of cholangitis: a nationwide cohort study.
Min YW; Kang D; Shin JY; Kang M; Park JK; Lee KH; Lee JK; Lee KT; Rhee PL; Kim JJ; Guallar E; Cho J; Lee H
Aliment Pharmacol Ther; 2019 Oct; 50(7):760-768. PubMed ID: 31448440
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors and the risk of colorectal cancer.
van Soest EM; van Rossum LG; Dieleman JP; van Oijen MG; Siersema PD; Sturkenboom MC; Kuipers EJ
Am J Gastroenterol; 2008 Apr; 103(4):966-73. PubMed ID: 18070237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]